Coronary revascularization--2009: state of the art

David P Taggart1

  • 1John Radcliffe Hospital, Oxford, UK. david.taggart@orh.nhs.uk

Insights

Coronary artery bypass grafting is superior for complex coronary artery disease. A multidisciplinary team approach ensures patient choice and informed consent for this gold-standard treatment.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Health Policy

Background:

  • Percutaneous coronary intervention (PCI) has advanced, but coronary artery bypass grafting (CABG) remains superior for complex coronary artery disease.
  • CABG offers better survival, reduced need for reintervention, and improved cost-effectiveness compared to PCI.
  • Current practices may limit patient access to optimal treatment due to individual "gatekeeper" roles.

Purpose of the Study:

  • To advocate for a multidisciplinary team approach in managing complex coronary artery disease.
  • To emphasize the importance of patient choice and informed consent in treatment decisions.
  • To promote CABG as the gold-standard intervention when appropriate.

Main Methods:

  • This is a conceptual and policy-based discussion, not a clinical trial.
  • Analysis of existing literature comparing CABG and PCI outcomes.
  • Review of ethical considerations in patient treatment pathways.

Main Results:

  • CABG demonstrates superior long-term survival and reintervention-free rates for complex cases.
  • Cost-effectiveness analyses favor CABG for extensive disease.
  • A multidisciplinary team model enhances transparency and patient autonomy.

Conclusions:

  • Coronary artery bypass grafting is the definitive treatment for complex coronary artery disease.
  • Implementing a multidisciplinary team approach is crucial for optimal patient care.
  • Ensuring patient choice and informed consent is paramount in cardiovascular intervention decisions.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...